Release Date: May 2004
Summary of Recommendations / Supporting Documents
Rating: I Recommendation.
Rationale: The USPSTF found fair evidence that screening with LDCT, CXR, or sputum cytology can detect lung cancer at an earlier stage than lung cancer would be detected in an unscreened population; however, the USPSTF found poor evidence that any screening strategy for lung cancer decreases mortality. Because of the invasive nature of diagnostic testing and the possibility of a high number of false-positive tests in certain populations, there is potential for significant harms from screening. Therefore, the USPSTF could not determine the balance between the benefits and harms of screening for lung cancer.
Screening for Lung Cancer, May 2004
Recommendation Statement (PDF File, 200 KB)
Summary of the Evidence (PDF File, 300 KB)
Systematic Evidence Review (File Download, 93 KB; PDF Files Download, 1 MB)
Return to Quick Menu: Topic Index
Return to USPSTF Home Page